Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL160460 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL7176200 | 1.00 | CA2 (0.33) | — | |
| Hydrochloric Acid SCHEMBL27964571 | 1.00 | CA2 (0.33) | — | |
| Hydrochloric Acid SCHEMBL31668382 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL693872 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL9453842 | 1.00 | CA2 (0.33) | — | |
| Hydrochloric Acid SCHEMBL608 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL28367342 | 1.00 | CA2 (0.33) | — | |
| Hydrochloric Acid SCHEMBL18009620 | 0.82 | — | — | |
| Water SCHEMBL1742784 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119409781-A | Purification method of Fim2/3 pilin without pertussis component antigen residues | 北京生物制品研究所有限责任公司 | 2025-02-11 | — | — | CN | claimed |
| CN-118844836-A | Long-acting disinfection and sterilization wet (towel) paper | 孙国明 | 2024-10-29 | — | — | CN | claimed |
| CN-117883371-A | Gatifloxacin eye drops and preparation method thereof | 广州仁恒制药有限公司 | 2024-04-16 | — | — | CN | claimed |
| US-11918655-B2 | Intranasal epinephrine formulations and methods for the treatment of disease | AEGIS THERAPEUTICS, LLC (US) | 2024-03-05 | — | — | US | claimed |
| US-20240024485-A1 | INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE | NEF ROYALTY SUB LLC | 2024-01-25 | — | — | US | claimed |
| CN-116349679-A | Composite disinfection and sterilization method | 孙国明 | 2023-06-30 | — | — | CN | claimed |
| CN-115819115-A | Preparation method of ceramic glaze | 康姆罗拉有限公司 | 2023-03-21 | — | — | CN | claimed |
| CN-110898002-B | Bone peptide injection and preparation method and application thereof | 湖北威仕生物药业股份有限公司 | 2022-05-10 | — | — | CN | claimed |
| CN-113751495-B | Soil remediation agent for chlorophenol pollution | 安徽大学 | 2022-04-22 | — | — | CN | claimed |
| JP-60253869-A | — | — | None | — | — | JP | disclosed |
| CN-117126138-B | Compound for degrading target protein in ubiquitin-proteasome system, and preparation method and application thereof | 深圳湾实验室坪山生物医药研发转化中心 | 2026-05-22 | — | — | CN | disclosed |
| US-20260132413-A1 | AROGENATE DEHYDROGENASE POLYNUCLEOTIDES, POLYPEPTIDES AND METHODS OF USING THE SAME | WISCONSIN ALUMNI RES FOUNDATION (US) | 2026-05-14 | — | — | US | disclosed |
| EP-3010517-B1 | IMMUNOTHERAPY COMPOSITION AND USE THEREOF | ONDEK PTY LTD (AU) | 2026-04-08 | — | — | EP | disclosed |
| EP-3996680-B1 | STABLE FORMULATIONS OF RECOMBINANT PROTEINS | UNICHEM LAB LTD (IN) | 2026-03-11 | — | — | EP | disclosed |
| WO-1998030575-A1 | BIOCONJUGATION OF MACROMOLECULES | PROLIGO LLC (US) | 1998-07-16 | — | — | WO | disclosed |
| WO-1998014690-A2 | SETTING COMPOSITION FOR WELL OPERATIONS | SOFITECH N.V. (BE) | 1998-04-09 | — | — | WO | disclosed |
| US-5733787-A | COPPER IONS, HYDROPEROXIDE, CHELATING AGENT | BAYER CORPORATION (US) | 1998-03-31 | — | — | US | disclosed |
| US-4822733-A | MONITORING TWO PHOTOPHORE-LABELLED PROBES, EMISSION LIVES, LUMINESCENCE | AMOCO CORPORATION (US) | 1989-04-18 | — | — | US | disclosed |
| JP-S60253869-A | REAGENT FOR MESURING ANTI-ARTIFICIAL NUCLEUS ANTIGEN ANTIBODY | MITSUI PHARMACEUT INC | 1985-12-14 | — | — | JP | disclosed |
| US-4138443-A | USING AN ACTIVATED ALUMINA SUPPORTED RHODIUM CATALYST ALSO CONTAINING ZINC, COPPER, NICKEL, COBALT AND/OR IRON | SOCIETE FRANCAISE DES PRODUITS POUR CATALYSE "PROCATALYSE" (FR) | 1979-02-06 | — | — | US | disclosed |